Ben ik depressief?
Pillie Willie donatie
Vriendelijke groet,
Willy Witsel
Slaapstoornissen en depressie
Bij depressie komen ook vaak slaapstoornissen voor. Slecht inslapen en en slecht doorslapen zijn de voornaamste problemen. Als deze slaapstoornissen worden aangepakt verminderen vaak de depressieve gevoelens. Er zijn verschillende methoden om slaapstoornissen effectief te behandelen:- Met behulp van een lage dosis (5 - 10mg) amitriptyline. Amitriptyline is een geneesmiddel van de antidepressiva klasse. Een lage dosis amitriptyline werkt beter dan traditionele slaapmiddelen omdat het er voor zorgt dat u dieper slaapt.
- Met 5 - 10mg melatonine. Melatonine is het zogenaamde "slaaphormoon". Het is een natuurlijke stof en werkt waarschijnlijk levensverlengend.
- Met behulp van een combinatie, tryptofaan, valeriaan, GABA en magnesium. Het gebruik van tryptofaan verbetert niet alleen de slaap maar verlicht ook enigszins de depressieve klachten. Magnesium geeft ook iets extra's. Het verbetert de stress bestendigheid. Magnesium suppletie wordt door orthomoleculaire artsen gezien als "eerste hulp bij stress".
St. Janskruid (hypericum) een natuurlijke antidepressivum
Er zijn een groot aantal wetenschappelijke studies beschikbaar die aangeven dat St. Janskruid (hypericum) als natuurlijke antidepressivum gebruikt kan worden. St. Janskruid (hypericum) heeft geen bijwerkingen zoals prozac en cipramil etc.Orthomoleculaire geneeskunde wat is dat?
Het behandelingsprotocol voor depressie (depressiviteit) is ontwikkeld op basis van principes uit de orthomoleculaire geneeskunde. Orthomoleculaire geneeskunde wat is dat nu weer? Dat is eenvoudig uitgelegd. “Ortho” betekent “goede” en “moleculair” is een ander woord voor “molecuul”. Dus orthomoleculaire geneeskunde betekent geneeskunde met goede moleculen, dus: genezing m.b.v. vitamines, mineralen, aminozuren, enzymen en spoorelementen. Orthomoleculaire geneeskunde is een geneeskunde waarbij geprobeerd wordt het lichaam te ondersteunen zich zelf te genezen. Dat lukt niet altijd, maar vaak wel en ook voor de orthomoleculaire geneeskunde geldt: voorkomen is beter dan genezen.Orthomoleculair informatiecentrum depressie (depressiviteit)
- Treatment protocol depression - Automatische Nederlandse vertaling
- Wetenschappelijke informatie over voedingssupplementen
Wetenschappelijk onderzoek depressie (depressiviteit)
Het protocol voor de behandeling depressie is op basis van wetenschappelijke publicaties ontwikkeld. Hierbij is gebruik gemaakt van de National Library of Medicine. Daar waar mogelijk werden studies die opgezet zijn volgens het "placebo controlled cross-over" principe gebruikt. Andere vormen die vaak werden gebruik zijn reviews en epidemiologisch onderzoek. Publicaties uit bladen als The Lancet, American Journal of Cardiology, The New England Journal of Medicine etc. hadden de voorkeur.Referenties depressie (depressiviteit) - St. Janskruid (hypericum)
- The efficacy of St. John's Wort in patients with minor depressive symptoms or dysthymia - a double-blind placebo-controlled study
We observed, a tendency toward a more frequent significant improvement of the non-dysthymic patient treated with PM235, though this did not reach the level of statistical significance. In a secondary analysis, pooling both hypericine-treated groups concluded that Hypericum has a clinical significant effect in minor depressed patients with HAM-D up to 17. This finding was significant only in non-dysthymic patients. - Predicting stable treatment response in patients with major depression treated with hypericum extract WS 5570/5572
A substantial fraction of the patients treated with Hypericum extracts WS(R) 5570/5572 showed a meaningful reduction of depressive symptoms during the first two weeks of treatment (early improvement), which was found to be a sensitive predictor of sustained response. The results determined for the herbal extracts were comparable to those for effective synthetic antidepressants investigated previously. - A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder
St John's wort was significantly more effective than fluoxetine and showed a trend toward superiority over placebo. A (25%) smaller than planned sample size is likely to account for the lack of statistical significance for the advantage (indicating a moderate effect size, d = 0.45) of St John's wort over placebo. - St John's wort for depression: meta-analysis of randomised controlled trials
Current evidence regarding Hypericum extracts is inconsistent and confusing. In patients who meet criteria for major depression, several recent placebo-controlled trials suggest that Hypericum has minimal beneficial effects while other trials suggest that Hypericum and standard antidepressants have similar beneficial effects. - Efficacy and tolerability of Hypericum extract STW 3-VI in patients with moderate depression: a double-blind, randomized, placebo-controlled clinical trial
The study provided evidence that Hypericum extract STW 3-VI in a once-daily dosing regimen may be an effective and well-tolerated option for patients with moderate depressive disorders. - Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial
H. perforatum extract WS 5570 was found to be safe and more effective than placebo for the treatment of mild to moderate depression.
Referenties depressie (depressiviteit) - SAMe (S-adenosylmethionine)
- Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence
SAMe is well tolerated and relatively free of adverse effects, although some cases of mania have been reported in bipolar patients. Overall, SAMe appears to be safe and effective in the treatment of depression, but more research is needed to determine optimal doses. Head-to-head comparisons with newer antidepressants should help to clarify SAMe's place in the psychopharmacologic armamentarium. - AS-adenosyl-l-methionine (SAMe) as antidepressant: meta-analysis of clinical studies
The efficacy of SAMe in treating depressive syndromes and disorders is superior with that of placebo and comparable to that of standard tricyclic antidepressants. Since SAMe is a naturally occurring compound with relatively few side-effects, it is a potentially important treatment for depression - Double-blind, placebo-controlled study of S-adenosyl-L-methionine in depressed postmenopausal women
There was a significantly greater improvement in depressive symptoms in the group treated with SAMe compared to the placebo group from day 10 of the study. Side effects were mild and transient. - Oral S-adenosylmethionine in depression: a randomized, double-blind, placebo-controlled trial
The results suggest that oral S-adenosylmethionine is a safe, effective antidepressant with few side effects and a rapid onset of action. S-Adenosylmethionine induced mania in a patient with no history of mania. S-Adenosylmethionine may be useful for patients who cannot tolerate tricyclic anti-depressants. These findings support a role for methylation in the pathophysiology of depression.
Referenties depressie (depressiviteit) - Tryptofaan
- Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan
This paper reviews the preclinical and clinical evidence regarding the use of the dietary supplement 5-hydroxytryptophan (5-HTP) for the treatment of depression - 5-Hydroxytryptophan: a clinically-effective serotonin precursor
Therapeutic administration of 5-HTP has been shown to be effective in treating a wide variety of conditions, including depression, fibromyalgia, binge eating associated with obesity, chronic headaches, and insomnia. - Aspects of tryptophan metabolism in health and disease: a review
- 5-Hydroxytryptophan: a clinically-effective serotonin precursor
Therapeutic administration of 5-HTP has been shown to be effective in treating a wide variety of conditions, including depression, fibromyalgia, binge eating associated with obesity, chronic headaches, and insomnia.
Referenties depressie (depressiviteit) - omega-3
- Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry
The preponderance of epidemiologic and tissue compositional studies supports a protective effect of omega-3 EFA intake, particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), in mood disorders. Meta-analyses of randomized controlled trials demonstrate a statistically significant benefit in unipolar and bipolar depression (p = .02). - Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes
Results are consistent with previous reports in depressed patients without CAD, and with literature concerning omega-3 levels and risk of CAD events. Dietary, genetic, and hormonal factors may all play a role in both depression and CAD. Both prospective studies and randomized trials are needed to help clarify the interrelationships - Neurobehavioral aspects of omega-3 fatty acids: possible mechanisms and therapeutic value in major depression
Omega-3 fatty acids have been the subject of volumes of international research, the results of which indicate these substances may have therapeutic value in a number of medical conditions. An emerging area of research is examining the neurobehavioral aspects of omega-3 fatty acids (alpha-linolenic, eicosapentaenoic, docosahexaenoic) and the critical role of these essential fats in the functioning of the central nervous system. Investigations have linked omega-3 fatty acids to a number of neuropsychiatric disorders, including depression. - Omega-3 fatty acids in the treatment of psychiatric disorders
Epidemiological studies indicate an association between depression and low dietary intake of omega-3 fatty acids, and biochemical studies have shown reduced levels of omega-3 fatty acids in red blood cell membranes in both depressive and schizophrenic patients - omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study
The results of this study suggest that E-EPA may be a safe and effective form of monotherapy for women with moderately severe borderline personality disorder - A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs
Treatment with ethyl-eicosapentaenoate at a dosage of 1 g/d was effective in treating depression in patients who remained depressed despite adequate standard therapy - Docosahexanoic acid and omega-3 fatty acids in depression
Geographic areas where consumption of DHA is high are associated with decreased rates of depression. DHA deficiency states, such as alcoholism and the postpartum period, also are linked with depression. Individuals with major depression have marked depletions in omega-3 FAs (especially DHA) in erythrocyte phospholipids compared with controls. These data suggest that DHA may be associated with depression, and the limited data available on supplementation with DHA or other omega-3 FAs seem to support the hypothesis that DHA may have psychotropic effects.
Referenties depressie (depressiviteit) - Amitriptyline
- Management of sleep disorders in fibromyalg
Tricyclic drugs, such as amitriptyline and cyclobenzaprine, may provide long term benefit for improving sleep but may not have a continuing benefit beyond one month for reducing pain
SITE MAP
- Candida: Candida infectie - Vaginale infectie - CVS/ME: Chronische vermoeidheid Syndroom - Diabetische complicaties: Behandeling diabetische complicaties - Neuropathie - Retinopathie - Nefropathie - Bloeduiker stabilisatie - Hart en vaatziekten: Behandeling Cardiomyopathie (Hartfalen) - Treatment Cardiomyopathy (Heart Failure) - Hoge bloeddruk - Cholesterol verlaging - Aderverkalking (atherosclerose - arteriosclerose) - Levensverlenging: 100 jaren jong - DHEA - Melatonine - 65+ - Kanker: - Ondersteuningstherapie bij kanker - Artrose en artritis: - Artrose - Artritis - Arthrose und Arthritis - Fibromyalgie: - Behandeling Fibromyalgie: introductie - Urinewegen: - Prostaatklachten - Blaasontsteking - Voeding: Voeding wat is er mis mee - Melk BAH!! - Suiker vergif voor je lichaam - Aanvulling onvolwaardige voeding - Vitamine supplementen: Voedingssupplementen - Overgewicht: - Overgewicht Home page - SLIM Home page - Andere artikelen: - HPU - Astma - Multiple Sclerosis (MS) - Psoriasis - Plus - Depressie - Algemeen behandelingsforum - Orthomoleculaire Geneeskunde -
- Candida: Candida infectie - Vaginale infectie - CVS/ME: Chronische vermoeidheid Syndroom - Diabetische complicaties: Behandeling diabetische complicaties - Neuropathie - Retinopathie - Nefropathie - Bloeduiker stabilisatie - Hart en vaatziekten: Behandeling Cardiomyopathie (Hartfalen) - Treatment Cardiomyopathy (Heart Failure) - Hoge bloeddruk - Cholesterol verlaging - Aderverkalking (atherosclerose - arteriosclerose) - Levensverlenging: 100 jaren jong - DHEA - Melatonine - 65+ - Kanker: - Ondersteuningstherapie bij kanker - Artrose en artritis: - Artrose - Artritis - Arthrose und Arthritis - Fibromyalgie: - Behandeling Fibromyalgie: introductie - Urinewegen: - Prostaatklachten - Blaasontsteking - Voeding: Voeding wat is er mis mee - Melk BAH!! - Suiker vergif voor je lichaam - Aanvulling onvolwaardige voeding - Vitamine supplementen: Voedingssupplementen - Overgewicht: - Overgewicht Home page - SLIM Home page - Andere artikelen: - HPU - Astma - Multiple Sclerosis (MS) - Psoriasis - Plus - Depressie - Algemeen behandelingsforum - Orthomoleculaire Geneeskunde -
